Biomea Fusion Stock Analysis

Biomea Stock Analysis Notes

About 42.0% of the company shares are held by institutions such as insurance companies. The book value of Biomea Fusion was currently reported as 0.47. The company recorded a loss per share of 3.0. Biomea Fusion had not issued any dividends in recent years. Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. The company was incorporated in 2017 and is headquartered in Redwood City, California. Biomea Fusion operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people. For more info on Biomea Fusion please contact the company at 650 980 9099 or go to https://biomeafusion.com.

Biomea Fusion Investment Alerts

Biomea Fusion Upcoming and Recent Events

Biomea Largest EPS Surprises

View All Earnings Estimates

Biomea Stock Institutional Investors

Note, although Biomea Fusion's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Biomea Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 106.76 M.

Biomea Profitablity

Management Efficiency

Biomea Fusion has return on total asset (ROA) of (0.6873) % which means that it has lost $0.6873 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7054) %, meaning that it created substantial loss on money invested by shareholders. Biomea Fusion's management efficiency ratios could be used to measure how well Biomea Fusion manages its routine affairs as well as how well it operates its assets and liabilities. As of October 20, 2025, Return On Tangible Assets is expected to decline to -1.82. The current year's Return On Capital Employed is expected to grow to -2.35. At present, Biomea Fusion's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 10.6 M, whereas Net Tangible Assets are forecasted to decline to about 80.4 M.

Technical Drivers

As of the 20th of October, Biomea Fusion shows the Risk Adjusted Performance of (0.01), standard deviation of 6.05, and Mean Deviation of 3.67. Biomea Fusion technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Biomea Fusion Price Movement Analysis

Study

Hilbert Transform Instantaneous Trendline Hilbert Transform Instantaneous Trendline Triple Exponential Moving Average Parabolic SAR Extended Simple Moving Average Triangular Moving Average Double Exponential Moving Average All Moving Average MidPoint over period Weighted Moving Average Bollinger Bands MESA Adaptive Moving Average Midpoint Price over period Triple Exponential Moving Average T3 Parabolic SAR Exponential Moving Average MAVP Kaufman Adaptive Moving Average

Biomea Fusion Insider Trading Activities

Biomea Fusion Outstanding Bonds

Biomea Fusion Predictive Daily Indicators

Biomea Fusion Forecast Models

Biomea Fusion's time-series forecasting models are one of many Biomea Fusion's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biomea Fusion's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biomea Fusion prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biomea shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biomea Fusion. By using and applying Biomea Stock analysis, traders can create a robust methodology for identifying Biomea entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biomea analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biomea analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Biomea Fusion stock analysis indicators help investors evaluate how Biomea Fusion stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Biomea Fusion shares will generate the highest return on investment. By understating and applying Biomea Fusion stock analysis, traders can identify Biomea Fusion position entry and exit signals to maximize returns.

When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.